Cancer Therapy News and Research

RSS

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

ScinoPharm Taiwan Ltd. and Coland Holdings Ltd. announced today that they have formed a strategic alliance to develop a series of generic oncological drugs for Mainland China.

10 May 2013

New data help explain hospital pricing, but experts caution that Medicare and insurers get much lower rates

Although the government releases a list of what hospitals across the country charge for common procedures in an effort to make health costs more transparent, few patients or their insurers pay that.

10 May 2013

Researchers discover novel mechanism of tumor hypoxia

An article published recently in Tumor Microenvironment and Therapy - an open access journal by Versita, defines a novel mechanism of tumor hypoxia induced by the longitudinal gradient of residual oxygen along tumor vessels as they transverse the tumor.

10 May 2013

USF, Aetna to examine influence of genetic testing on breast cancer treatment

The University of South Florida and Aetna are launching a ground-breaking study that will examine the influence genetic testing may have on clinical treatment decisions among breast cancer patients and their doctors.

10 May 2013

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

In cancer, mutations in proteins that control cell growth are common, leading to unrestrained cellular proliferation and tumor formation.

9 May 2013

First Edition: May 9, 2013

Today's headlines include reports about the politics surrounding the health law, both in terms of the latest GOP push for repeal and the Obama administration's implementation efforts.

9 May 2013

New Mosby's Index now available in easier-to-navigate format

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the revamping of Mosby's Index, the most robust journal abstracts and indexing database available for nurses and other healthcare professionals.

9 May 2013

Antitumor medication from natural origins on the rise

Natural phenolic compounds play an important role in cancer prevention and treatment. Researchers who examine the medicinal herbs and dietary plants that can aid in cancer treatment and prevention have found that antitumor medication from natural origins is on the rise.

9 May 2013

Protein tumor necrosis factor-alpha is a powerful weapon to control cancer

The protein tumor necrosis factor-alpha (TNF-alpha) is a powerful weapon in the arsenal to control cancer. Unfortunately, as is the case with many potent cancer therapies, the use of TNF-alpha as an anti-cancer therapy has been severely limited.

8 May 2013

Seven-year quest to understand how breast cancer cells resist treatment

A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death.

8 May 2013

Study shows turning up few microRNAs may offer much anti-breast-cancer activity

A University of Colorado Cancer Center study recently published in the journal Cell Death & Disease shows that turning up a few microRNAs a little may offer as much anti-breast-cancer activity as turning up one microRNA a lot - and without the unwanted side effects.

8 May 2013

New guidelines for radiation therapy after prostatectomy

Based on a major effort co-led by Richard Valicenti, UC Davis Department of Radiation Oncology Professor and Chair, the nation's leading urological and radiation oncology organizations today announced a new guideline for radiation therapy after prostatectomy.

8 May 2013

Clinical data of cabozantinib to be presented at ASCO meeting

Exelixis, Inc. announced today that cabozantinib will be the subject of nine separate data presentations at the upcoming 2013 Annual Meeting of the American Society of Clinical Oncology.

8 May 2013

Advances in lung cancer treatment have major impact on short- and long-term outcomes

The American College of Chest Physicians third edition of evidence-based lung cancer guidelines, Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, recommends offering low-dose computed tomography scanning for lung cancer screening to people with a significant risk of lung cancer due to age and smoking history.

8 May 2013

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.

7 May 2013

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

Cancer chemotherapy can cause peripheral neuropathy-nerve damage often resulting in pain and muscle weakness in the arms and legs. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that chemo also induces an insidious type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation.

6 May 2013

New Department of Health Services Research for quality cancer care

Oncologist and cancer care outcomes researcher Sharon H. Giordano, M.D., leads the new Department of Health Services Research at The University of Texas MD Anderson Cancer Center, a multidisciplinary area of research that examines the delivery, quality and costs of health care.

5 May 2013

Cancer Therapy News and Research

ScinoPharm Taiwan, Coland Holdings partner to develop generic oncological drugs for China

New data help explain hospital pricing, but experts caution that Medicare and insurers get much lower rates

Researchers discover novel mechanism of tumor hypoxia

USF, Aetna to examine influence of genetic testing on breast cancer treatment

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

First Edition: May 9, 2013

New Mosby's Index now available in easier-to-navigate format

Antitumor medication from natural origins on the rise

Protein tumor necrosis factor-alpha is a powerful weapon to control cancer

Seven-year quest to understand how breast cancer cells resist treatment

Study shows turning up few microRNAs may offer much anti-breast-cancer activity

New guidelines for radiation therapy after prostatectomy

Clinical data of cabozantinib to be presented at ASCO meeting

Advances in lung cancer treatment have major impact on short- and long-term outcomes

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

New Department of Health Services Research for quality cancer care

Expert to explain how drugs induce damage to DNA in public lecture on May 16

UC San Diego Health System receives national award for providing quality care to cancer patients

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News